Variant report
Variant | esv3493518 |
---|---|
Chromosome Location | chr7:71756948-71757876 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:71752349..71754126-chr7:71756443..71759399,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377211733 | chr7:71756948-71756949 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6460711 | chr7:71756949-71756950 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs576312816 | chr7:71756950-71756951 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533928666 | chr7:71756967-71756968 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141637172 | chr7:71756973-71756974 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78463452 | chr7:71756986-71756987 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10244985 | chr7:71756998-71756999 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs565224843 | chr7:71757023-71757024 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577319366 | chr7:71757024-71757025 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185452388 | chr7:71757070-71757071 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs150525040 | chr7:71757082-71757083 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574865855 | chr7:71757103-71757104 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs62459264 | chr7:71757124-71757125 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs563641641 | chr7:71757128-71757129 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556512916 | chr7:71757135-71757136 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139516860 | chr7:71757145-71757146 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375914724 | chr7:71757169-71757170 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142777377 | chr7:71757200-71757201 | Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532326557 | chr7:71757208-71757209 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547324206 | chr7:71757243-71757244 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561545213 | chr7:71757264-71757265 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190954044 | chr7:71757298-71757299 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182087360 | chr7:71757316-71757317 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550039379 | chr7:71757322-71757323 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569279046 | chr7:71757328-71757329 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574993074 | chr7:71757352-71757353 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536650066 | chr7:71757357-71757358 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558783069 | chr7:71757365-71757366 | Weak transcription Enhancers Flanking Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570047182 | chr7:71757420-71757421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs117051263 | chr7:71757479-71757480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535645758 | chr7:71757507-71757508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574995057 | chr7:71757511-71757512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186727423 | chr7:71757514-71757515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563774725 | chr7:71757526-71757527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs376983278 | chr7:71757636-71757637 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575669581 | chr7:71757672-71757673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565591448 | chr7:71757674-71757675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546261809 | chr7:71757675-71757676 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565183824 | chr7:71757677-71757678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191923792 | chr7:71757680-71757681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547553003 | chr7:71757687-71757688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559248451 | chr7:71757699-71757700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199615574 | chr7:71757705-71757706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529860953 | chr7:71757707-71757708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs13241064 | chr7:71757718-71757719 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547832634 | chr7:71757722-71757723 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547904608 | chr7:71757733-71757734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530415666 | chr7:71757747-71757748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147402685 | chr7:71757755-71757756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371098418 | chr7:71757761-71757762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Biliary cancer | 19435499 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Astrocytoma | 22246337 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16461572 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Chordoma | 18071362 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:71732600-71760600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr7:71732800-71758000 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr7:71756000-71757000 | ZNF genes & repeats | Fetal Thymus | thymus |
4 | chr7:71756600-71757200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr7:71756600-71757200 | Weak transcription | Thymus | Thymus |
6 | chr7:71756600-71757800 | Enhancers | Primary hematopoietic stem cells | blood |
7 | chr7:71756800-71757000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
8 | chr7:71756800-71757800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr7:71757000-71757200 | Strong transcription | Fetal Thymus | thymus |
10 | chr7:71757000-71758000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr7:71757200-71757400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr7:71757200-71757400 | Genic enhancers | Fetal Thymus | thymus |
13 | chr7:71757200-71758400 | Enhancers | Dnd41 | blood |
14 | chr7:71757200-71758800 | Enhancers | Thymus | Thymus |
15 | chr7:71757400-71757800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr7:71757400-71758800 | Enhancers | Fetal Thymus | thymus |
17 | chr7:71757800-71758600 | Flanking Active TSS | Primary hematopoietic stem cells | blood |
18 | chr7:71757800-71758600 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
19 | chr7:71757800-71758600 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |